Biblio Discovery — Demo Discovery Service

37 hasil untuk "Howard Colman"

Menampilkan 1–20 · 0,77 detik · RSS

  1. Artikel Jurnal

    Challenges of targeting BRAF V600E mutations in adult primary brain tumor patients: a report of two cases

    Matthew Smith-Cohn; Christian Davidson; Howard Colman dkk.

    CNS Oncology, Vol. 8 No. 4 · 2019 · Inggris · DOAJ Scopus

    Aim: Therapeutic targeting of BRAF alterations in primary brain tumor patients has demonstrated clinical activity in case reports and early trials; however, there is limited high-level evidence of the efficacy. Patients & results: Targeting BRAF V600E mutations with concurrent dabrafenib and…

  2. Artikel Jurnal

    Bevacizumab is Effective for Recurrent Papillary Tumor of the Pineal Region: First Report

    Adam L. Cohen; Karen Salzman; Cheryl Palmer dkk.

    Case Reports in Oncology, Vol. 6 No. 2 · 2013 · Inggris · DOAJ Scopus

    Papillary tumor of the pineal region (PTPR) is a rare brain tumor that probably arises from ependymal cells. There are no known systemic treatments for PTPR once it is refractory to surgery and radiation. We present the first case of a durable radiographic and clinical response of a PTPR to…

  3. Artikel Jurnal

    First line immunotherapy extends brain metastasis free survival, improves overall survival, and reduces the incidence of brain metastasis in patients with advanced melanoma

    Xuechen Wang; Benjamin Haaland; Siwen Hu‐Lieskovan dkk.

    Cancer Reports, Vol. 4 No. 6 · 2021 · Inggris · DOAJ Scopus

    Abstract Background Recent advances in targeted therapy and immunotherapy have improved the prognosis of melanoma patients but brain metastasis remains a major challenge. Currently, it is unclear how existing therapies can be best used to prevent or treat brain metastasis in melanoma patients. Aims…

  4. Artikel Jurnal Teks lengkap

    Intermittent Induction of HIF-1α Produces Lasting Effects on Malignant Progression Independent of Its Continued Expression

    Hyunsung Choi; David L. Gillespie; Shauna Berg dkk.

    PLOS ONE, Vol. 10 No. 4 · 2015 · Inggris · PLOS Scopus

    Dysregulation of hypoxia-inducible transcription factors HIF-1α and HIF-2α correlates with poor prognosis in human cancers; yet, divergent and sometimes opposing activities of these factors in cancer biology have been observed. Adding to this complexity is that HIF-1α apparently possesses…

    Juga tersedia di: DOAJ

  5. Artikel Jurnal

    The contribution of the rs55705857 G allele to familial cancer risk as estimated in the Utah population database

    Sarah Hummel; Wendy Kohlmann; Thomas M. Kollmeyer dkk.

    BMC Cancer, Vol. 19 No. 1 · 2019 · Inggris · DOAJ Scopus

    Abstract Background IDH1/2 mutated glioma has been associated with a germline risk variant, the rs55705857 G allele. The Utah Population Database (UPDB), a computerized genealogy of people in Utah, is a unique resource to evaluate cancer risk in related individuals. Methods One hundred and two…

  6. Artikel Jurnal Teks lengkap

    Phase Ib/II Study of Pamiparib Plus Radiation Therapy and/or Temozolomide in Adult Patients with Treatment-Naïve or Recurrent/Refractory Glioblastoma

    Anna F. Piotrowski; Kent Shih; Pierre Giglio dkk.

    Current Oncology, Vol. 32 No. 10 · 2025 · Inggris · DOAJ Scopus

    Pamiparib, a small-molecule poly (ADP-ribose) polymerase (PARP) 1/2 inhibitor, demonstrates strong PARP-DNA complex trapping, antitumor activity, and blood–brain barrier penetration. This phase Ib/II dose-escalation study (NCT03150862) investigated pamiparib’s tolerability/safety and efficacy when…

  7. Artikel Jurnal

    Regulation of HGF Expression by ΔEGFR-Mediated c-Met Activation in Glioblastoma Cells

    Jeannine Garnett; Vaibhav Chumbalkar; Brian Vaillant dkk.

    Neoplasia: An International Journal for Oncology Research, Vol. 15 No. 1 · 2013 · Inggris · DOAJ Scopus

    The hepatocyte growth factor receptor (c-Met) and a constitutively active mutant of the epidermal growth factor receptor (ΔEGFR/EGFRvIII) are frequently overexpressed in glioblastoma (GBM) and promote tumorigenesis. The mechanisms underlying elevated hepatocyte growth factor (HGF) production in GBM…

  8. Artikel Jurnal

    Olutasidenib in recurrent/relapsed locally advanced or metastatic IDH1-mutated chondrosarcoma: phase 1b/2 trial

    Robin L. Jones; Roman Groisberg; Jean-Yves Blay dkk.

    Nature Communications, Vol. 17 No. 1 · 2026 · Inggris · DOAJ Scopus

    Abstract Chondrosarcomas are rare cartilaginous neoplasms with limited treatment options. Isocitrate dehydrogenase 1/2 (mIDH1/2) mutations occur in 65% of chondrosarcomas. Here we report safety and efficacy of olutasidenib, an mIDH1 inhibitor, evaluated in patients with locally advanced or…

  9. Artikel Jurnal Teks lengkap

    Exploratory Analysis of the Copy Number Alterations in Glioblastoma Multiforme

    Pablo Freire; Marco Vilela; Helena Deus dkk.

    PLoS ONE, Vol. 3 No. 12 · 2008 · Inggris · PLOS Scopus

    Background: The Cancer Genome Atlas project (TCGA) has initiated the analysis of multiple samples of a variety of tumor types, starting with glioblastoma multiforme. The analytical methods encompass genomic and transcriptomic information, as well as demographic and clinical data about the sample…

    Juga tersedia di: DOAJ

  10. Artikel Jurnal

    Combined inhibition of focal adhesion kinase and RAF/MEK elicits synergistic inhibition of melanoma growth and reduces metastases

    Jared Almazan; Tursun Turapov; David A. Kircher dkk.

    Cell Reports Medicine, Vol. 6 No. 2 · 2025 · Inggris · DOAJ Scopus

    Summary: This study addresses the urgent need for effective therapies for patients with brain metastases from cutaneous melanoma, a major cause of treatment failure despite recent therapeutic advances. Utilizing mouse models that mimic human melanoma brain metastases, this study investigates the…

  11. Artikel Jurnal

    The association of diabetes mellitus and routinely collected patient‐reported outcomes in patients with cancer. A real‐world cohort study

    Dominik J. Ose; Emmanuel Adediran; Bayarmaa Mark dkk.

    Cancer Medicine, Vol. 13 No. 20 · 2024 · Inggris · DOAJ Scopus

    Abstract Objective Current studies have indicated that diabetes mellitus (DM) is highly prevalent in patients with cancer, but there is little research on consequences on the well‐being of patients during cancer treatment. This analysis evaluates the relationship between DM and patient‐reported…

  12. Artikel Jurnal

    Randomized Phase II and Biomarker Study of Pembrolizumab plus Bevacizumab versus Pembrolizumab Alone for Patients with Recurrent Glioblastoma

    Lakshmi Nayak; Annette M. Molinaro; Katherine B. Peters dkk.

    Clinical Cancer Research · 2020 · Inggris · OpenAlex Scopus

    Abstract Purpose: VEGF is upregulated in glioblastoma and may contribute to immunosuppression. We performed a phase II study of pembrolizumab alone or with bevacizumab in recurrent glioblastoma. Patients and Methods: Eighty bevacizumab-naïve patients with recurrent glioblastoma were randomized to…

  13. Artikel Jurnal

    Mutant IDH1 Promotes Glioma Formation In Vivo

    Beatrice Philip; Diana X. Yu; Mark R. Silvis dkk.

    Cell Reports, Vol. 23 No. 5 · 2018 · Inggris · DOAJ Scopus

    Summary: Isocitrate dehydrogenase 1 (IDH1) is the most commonly mutated gene in grade II–III glioma and secondary glioblastoma (GBM). A causal role for IDH1R132H in gliomagenesis has been proposed, but functional validation in vivo has not been demonstrated. In this study, we assessed the role of…

  14. Artikel Jurnal

    Systematic review of combinations of targeted or immunotherapy in advanced solid tumors

    Mustafa Khasraw; Susan M Chang; Amy B Heimberger dkk.

    Journal for ImmunoTherapy of Cancer, Vol. 9 No. 7 · 2021 · Inggris · DOAJ Scopus

    With rapid advances in our understanding of cancer, there is an expanding number of potential novel combination therapies, including novel–novel combinations. Identifying which combinations are appropriate and in which subpopulations are among the most difficult questions in medical research. We…

  15. Artikel Jurnal

    Multicellular immune ecotypes within solid tumors predict real-world therapeutic benefits with immune checkpoint inhibitors

    Xuefeng Wang; Tingyi Li; Islam Eljilany dkk.

    Nature Communications, Vol. 16 No. 1 · 2025 · Inggris · DOAJ Scopus

    Abstract Immune checkpoint inhibitors (ICIs) have transformed cancer treatment, yet predicting patient response remains a major challenge. Carcinoma ecotypes, which capture the cancer-immune interactions, show promise as prognostic biomarkers but remain untested in real-world settings. We compile…